Trulieve Cannabis Dividend

Dividend criteria checks 0/6

Trulieve Cannabis hat in der Vergangenheit keine Dividende gezahlt.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield	2.3%
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Earnings per share	-CA$2.26
Dividend yield forecast in 3Y	n/a

Recent dividend updates

No updates

Recent updates

Revenues Not Telling The Story For Trulieve Cannabis Corp. (CSE:TRUL) After Shares Rise 26%

Mar 31

Is Trulieve Cannabis (CSE:TRUL) A Risky Investment?

Feb 15

There's Reason For Concern Over Trulieve Cannabis Corp.'s (CSE:TRUL) Massive 29% Price Jump

Jan 16

Calculating The Intrinsic Value Of Trulieve Cannabis Corp. (CSE:TRUL)

Mar 06

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively

Jan 26

Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?

Aug 07

Are Trulieve Cannabis Corp. (CSE:TRUL) Investors Paying Above The Intrinsic Value?

Jul 03

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Reasonably Well

Mar 21

Stability and Growth of Payments

Fetching dividends data

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von TRUL in der Vergangenheit stabil geblieben ist.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von TRUL gestiegen sind.

Dividend Yield vs Market

Trulieve Cannabis Dividend Yield vs Market

How does TRUL dividend yield compare to the market?
Segment	Dividend Yield
Company (TRUL)	n/a
Market Bottom 25% (CA)	1.9%
Market Top 25% (CA)	6.3%
Industry Average (Pharmaceuticals)	2.3%
Analyst forecast in 3 Years (TRUL)	n/a

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von TRUL im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von TRUL im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Earnings Payout to Shareholders

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von TRUL, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Cash Payout to Shareholders

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da TRUL keine Ausschüttungen gemeldet hat.

Discover strong dividend paying companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Trulieve Cannabis Dividend

Dividend criteria checks 0/6

Key information

Recent dividend updates

Recent updates

Revenues Not Telling The Story For Trulieve Cannabis Corp. (CSE:TRUL) After Shares Rise 26%

Trulieve Cannabis Corp., Annual General Meeting, Jun 12, 2024

New minor risk - Shareholder dilution

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Trulieve Cannabis (CSE:TRUL) A Risky Investment?

Trulieve Cannabis Corp. to Report Q4, 2023 Results on Feb 29, 2024

There's Reason For Concern Over Trulieve Cannabis Corp.'s (CSE:TRUL) Massive 29% Price Jump

Trulieve Announces Appointment of Marie Zhang as Chief Operating Officer, Effective January 29, 2024

Trulieve Cannabis Corp. Announces Chief Financial Officer Changes

Trulieve Cannabis Corp. Announces Chief Financial Officer Changes

Trulieve Cannabis Corp. to Report Q3, 2023 Results on Nov 09, 2023

Trulieve Cannabis Corp. Announces Relocation of Medical Cannabis Dispensary in Melbourne, Florida

Trulieve Cannabis Corp. Announces Stepping Down of Steve White as President

Trulieve Cannabis Corp. Provides Revenue Guidance for the Third Quarter of 2023

Trulieve Cannabis Corp. Announces the Relocation of Medical Dispensary in Kissimmee, Florida

Trulieve Cannabis Corp. Announces CFO Changes

Trulieve Cannabis Corp. to Report Q2, 2023 Results on Aug 09, 2023

Trulieve Cannabis Corp. Announces Appointment of Tim Mullany as Chief Financial Officer

Trulieve Continues Optimization Efforts with Closure of California Retail Location and Plan to Wind Down Massachusetts Operations

Consensus EPS estimates fall by 33%

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Joy Malivuk Appoints as the Vice President, Chief Accounting Officer of Trulieve Cannabis Corp

Full year 2022 earnings: EPS misses analyst expectations

Now 22% undervalued after recent price drop

Calculating The Intrinsic Value Of Trulieve Cannabis Corp. (CSE:TRUL)

Trulieve Cannabis Corp. Announces to Begin Adult-Use Cannabis Sales At Relocated Bristol, CT Dispensary

Trulieve Cannabis Corp. to Report Q4, 2022 Results on Mar 01, 2023

Trulieve Cannabis Corp. Introduces New Products to West Virginia in February

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively

Trulieve Cannabis Corp. Launches Highsman Cannabis Products from NFL Legend Ricky Williams in Arizona

Trulieve Cannabis Corp. Announces Resignation of Rebecca L. Young as Chief Accounting Officer

Trulieve Cannabis Corp. Launches Khalifa Kush Cannabis in Maryland Through Exclusive Partnership with Wiz Khalifa

Trulieve Launches Khalifa Kush Cannabis in Pennsylvania Through Exclusive Partnership with Wiz Khalifa

Trulieve Cannabis Corp. Provides Earnings Guidance for the Year 2022

Trulieve Cannabis Corp. to Report Q3, 2022 Results on Nov 09, 2022

Trulieve Cannabis Corp. Launches Khalifa Kush Cannabis in Florida Through Exclusive Partnership with Wiz Khalifa

Trulieve Announces Opening of Relocated Edgewater Dispensary in Florida

Second quarter 2022 earnings: EPS misses analyst expectations

Trulieve Cannabis Corp. Revises Revenue Guidance for the Fiscal Year 2022

Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?

Trulieve Cannabis Corp. to Report Q2, 2022 Results on Aug 10, 2022

Consensus forecasts updated

Are Trulieve Cannabis Corp. (CSE:TRUL) Investors Paying Above The Intrinsic Value?

Founder recently bought CA$260k worth of stock

Trulieve Cannabis Corp. Opens Two Medical Dispensary in West Virginia

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Trulieve Cannabis Corp. Reiterates Earnings Guidance for 2022 and Provides Earnings Guidance for the Second Half of 2022

High number of new directors

Consensus forecasts updated

Consensus forecasts updated

Consensus EPS estimates fall by 64%

Full year 2021 earnings: Revenues in line with analyst expectations

Trulieve Cannabis Corp. Announces Impairment Charges for the Quarter Ended December 31, 2021

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Reasonably Well

Trulieve Cannabis Corp. to Report Q4, 2021 Results on Mar 30, 2022

Investor sentiment deteriorated over the past week

Trulieve Cannabis Corp. (CNSX:TRUL) acquired 64,000 sq. ft. Cultivation Facility in Phoenix.

Trulieve Cannabis Corp. Launches Sweet TalkTM and MomentaTM

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Trulieve First in Florida Market to Offer Live Diamonds, Company's Latest Hydrocarbon Extraction Product

High number of new directors

Trulieve Cannabis Corp. (CNSX:TRUL) acquired PurpleMed Healing Center.

Trulieve Cannabis Corp. Launches TruTonic

Investor sentiment improved over the past week

Trulieve Cannabis Corp. Debuts New Line of Concentrates Using Hydrocarbon Extraction

An unknown buyer acquired Ten Trulieve Cannabis Locations in Floridan from Trulieve Cannabis Corp. (CNSX:TRUL) for $14.8 million.

Trulieve Becomes First MSO to Launch Clone Sales in Massachusetts

Chair, President & CEO recently bought CA$123k worth of stock

Is Trulieve Cannabis (CSE:TRUL) Using Too Much Debt?

Second quarter 2021 earnings released: EPS US$0.33 (vs US$0.17 in 2Q 2020)

Trulieve Introduces New Brand Portfolio Designed to Serve Consumers in Adult-Use and Medical Markets

High number of new directors

Independent Director Michael O’Donnell has left the company

Independent Director George Hackney has left the company